​

Funding Round

Series C - Endocyte

Series C - Endocyte

Investment Firm

Overview

Endocyte is a biopharmaceutical company that develops receptor-targeted therapeutics to treat cancer and inflammatory diseases.

Announced Date

Mar 26, 2007

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

5

Investor Name
Participant InvestorCID Capital
Participant InvestorBurrill & Company
Participant InvestorBlue Chip Venture Company
Participant InvestorTriathlon Medical Venture Partners
Participant InvestorSanderling Ventures

Round Details and Background

Endocyte raised $15000000 on 2007-03-26 in Series C

Endocyte is a biopharmaceutical company that develops receptor-targeted therapeutics to treat cancer and inflammatory diseases.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 26, 2007
Series C - Endocyte
6-15.0M
Dec 27, 2010
Debt Financing - Endocyte
-8.1M
Aug 30, 2010
Venture Round - Endocyte
2-15.0M
Jan 19, 2010
Series C - Endocyte
6-26.0M

Recent Activity

There is no recent news or activity for this profile.